Ambien Hits Back at Roseanne: “Racism Is Not a Known Side Effect”

The just-fired TV host had blamed her sleeping pills for a bigoted tweet.

Kristin Callahan/ZUMA

The manufacturer of Ambien is pushing back against Roseanne Barr’s attempt to blame the drug for a racist tweet she published and deleted Tuesday. 

“People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world,” Sanofi US, the company behind the commonly prescribed sleeping pill, said in a Wednesday statement. “While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.”

The company was responding to another since deleted tweet Barr sent on Wednesday, where the TV star claimed “ambien tweeting” prompted her to liken Valerie Jarrett, a former senior adviser to Barack Obama who is black, to an ape. Just hours after that tweet gained attention on social media, ABC said it was canceling Roseanne for what it denounced as an “abhorrent” and “repugnant” statement by Barr.

The 2018 reboot of the popular sitcom had been attracting high ratings—even while some jokes drew controversy and as Barr kept up her well-established record of promoting baseless, right-wing conspiracy theories.

Despite Barr’s announcement that she would soon be leaving Twitter, along with a public apology she sent to Jarrett, Barr continued to retweet right-wing conspiracy theories about the former Obama adviser well into Wednesday evening. Other Barr retweets suggested ABC was wrong to cancel Roseanne and that Barr thought the company had applied a double standard in choosing to dismiss her.


We recently wrapped up the crowdfunding campaign for our ambitious Mother Jones Corruption Project, and it was a smashing success. About 10,364 readers pitched in with donations averaging $45, and together they contributed about $467,374 toward our $500,000 goal.

That's amazing. We still have donations from letters we sent in the mail coming back to us, so we're on pace to hit—if not exceed—that goal. Thank you so much. We'll keep you posted here as the project ramps up, and you can join the hundreds of readers who have alerted us to corruption to dig into.

We Recommend


Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.


Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.


Share your feedback: We’re planning to launch a new version of the comments section. Help us test it.